Navigation Links
Bionovo Adds Dr. Debu Tripathy to Their Medical Advisory Board
Date:10/14/2009

h early signs of clinical efficacy coupled with excellent tolerability and exceptional safety. It is rare to see such early clinical success in an advanced breast cancer drug candidate. This is the sort of innovative therapy that the clinical community is urgently seeking."

Dr. Debu Tripathy has recently been appointed Professor of Medicine at the Keck School of Medicine at the University of Southern California (USC) and Co-Leader of the Women's Cancer Program at USC Norris Comprehensive Cancer Center. He will hold the Priscilla and Art Ulene Chair in Women's Cancer. Prior to joining USC, Dr. Tripathy served as Professor of Internal Medicine at the University of Texas Southwestern Medical Center at Dallas. He also served as the Director of the Komen/UT Southwestern Breast Cancer Research Program and held the Annette Simmons Distinguished Chair in Breast Cancer Research.

Dr. Tripathy has over 20 years of laboratory and clinical research experience. He was one of the pioneers that brought Herceptin through early and late stage clinical testing on behalf of Genentech to FDA approval of the first monoclonal antibody for breast cancer. He has received numerous prestigious awards, including the highly acclaimed Heroes Award, from the Breast Cancer Fund. Additionally, he has co-authored many books including "Breast Cancer: Beyond Convention" with world renowned physicians. Dr. Tripathy received his medical degree from Duke University School of Medicine. He completed his residency at Duke University and fellowship at the Cancer Research Institute at the University of California, San Francisco.

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived fro
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bionovo Announces Pricing of Securities Offering
2. Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency
3. Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
4. Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
5. Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
6. Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
7. Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
8. Bionovo to Present at the Cambria Capital Investor Meeting
9. Bionovo to Present at Wall Street Analyst Forums 20th Annual Institutional Investor Conference
10. Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
11. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Akeso Biomedical, Inc. , ... treatment of bacterial infections, microbial biofilms, and chronic wounds, ... board of directors. , Dr. Sinskey ... The Massachusetts Institute of Technology, or MIT. He has ... Dr. Sinskey also holds positions as Co-Director of the ...
(Date:10/22/2014)... sisters in high school have developed ways to measure ... use electronic stethoscopes, which electronically amplify body sounds, to ... heartbeats. Ilina, a senior at Port Huron Northern ... to detect early lung damage in people exposed to ... one breath cycle each from 16 smokers, 25 nonsmokers ...
(Date:10/22/2014)... (HealthDay News) -- Measures taken by Firestone officials at ... may have limited the spread of the disease there ... Firestone Natural Rubber Co. provides health services to about ... densely populated communities. Between Aug. 1 and Sept. ... among those 80,000 people. That incidence rate of 0.09 ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market ... of facts, figures and forecasts on the global medical ... forecast categories the Worldwide Medical Market Forecasts to ... views on the worldwide medical market to reveal key ... you data for 2010-2019, covering each country market individually, ...
(Date:10/20/2014)... The Advocator Group, LLC ... American Foundation for Suicide Prevention’s (AFSP) Out of the ... not-for-profit organization that hosts hundreds of community walks throughout ... are used to help understand and prevent suicide through ... as well. , The Advocator Group shares this ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3
... , , TOMBALL, Texas, ... that created relaxation category brand leader Purple Stuff; has released ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090914/DA75426 ) , , ... drink that combines energy, appetite control, calorie burners and 100% ...
... , ATLANTA, Sept. 15 As ... words." This month HIPAA.com launches its sister site, HIPAA TV, ... do and how to go about it. HIPAA TV expands ... demonstrations, case studies, and satire as they relate to HIPAA, ...
... , , ... people with disabilities and gain valuable advocacy tools at one of ... with Disabilities (MN-CCD). Learn how the 2009 legislative session impacts ... person-centered programs; and speak directly to legislators about your challenges and ...
... , , HARTFORD, Conn., Sept. ... health insurance these days than ever. But, when it comes to ... take advantage of their options when choosing benefits during Open Enrollment ... from Plan for Your Health , the health benefits public ...
... , , , ... the world,s leading research and advisory firms for pharmaceutical and ... Spain and U.K.) sales of Roche/Biogen Idec,s Rituxan/MabThera, Bristol-Myers Squibb/Merck,s ... in 2014, before falling to roughly $10 billion in 2018. ...
... treatments for bronchitis, asthma, researchers say , TUESDAY, ... genetic switch that makes mucus production go into overdrive ... ailments, a new study says. , Excessive mucus ... from asthma, cystic fibrosis, bronchitis, common colds and other ...
Cached Medicine News:Health News:Funktional Beverages, Inc. Creates the Ultimate Weight Management Sports Drink. 2Health News:Funktional Beverages, Inc. Creates the Ultimate Weight Management Sports Drink. 3Health News:HIPAA.com Launches HIPAA TV 2Health News:Disability Matters: Learn Your Rights, Preserve Your Independence 2Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 2Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 3Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 4Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 5Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 6Health News:Biosimilars of Rituxan, MabThera, Herceptin and Erbitux will Erode $8.2 Billion in U.S. and European Sales in 2018 2Health News:Biosimilars of Rituxan, MabThera, Herceptin and Erbitux will Erode $8.2 Billion in U.S. and European Sales in 2018 3
(Date:10/22/2014)...   BioNano Genomics , the genome mapping ... to purchase an Irys™ System . Among them ... (NCI), NIH Intramural Sequencing Center (NISC) and Genoscope (The ... comprehensive view of a genome was a major ... deliver the scalability or reliability to detect and ...
(Date:10/22/2014)... Oct. 21, 2014 Influenza will affect as many ... the United States as high as ... to spread is from person to person in respiratory droplets ... serve way of death, but kills much fewer people each ... done by human fluids including sweat, saliva, blood and other ...
(Date:10/22/2014)... , Oct. 22, 2014 Sanomedics International ... 2014 report by Global Research & Data Services, demand ... year from 2014 through 2018, as demand for more ... is the world,s largest market for thermometers, ... advanced thermometers is Sanomedics International Holdings, Inc. ...
Breaking Medicine Technology:BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2
... To thank customers for their continuous support of our ... beat watches, blood pressure monitors and so on, Shenzhen ... these products with discounts ranging from 65-20%. ... more suitable products to customers, Wuzhou Changlian has introduced ...
... June 8, 2011 Regulus Therapeutics Inc ., ... innovative medicines targeting microRNAs, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ... today announced the publication in Nature ... antagonism of microRNA-103 and microRNA-107 (miR-103/107). Data from a ...
Cached Medicine Technology:Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 2Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 3Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 4Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 5Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 6Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 7
Provides 30% more magnification and twice the field of view. Adjustable focus, with insufflator bulb....
Features a built-in throat illuminator, providing 30% more magnification and twice the field of view. Adjustable focus....
... Novus Spectra photocoagulator delivers power and ... solid-state (DPSS) technology. Diode side-pumping technology ... the compact Novus Spectra system, and ... beam output and system reliability from ...
A standard, durable and reliable indirect....
Medicine Products: